Berkshire Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.11M | Sell |
87,660
-6,485
| -7% | -$170K | 0.08% | 103 |
|
|
2026
Q1 | $2.64M | Sell |
94,145
-5,293
| -5% | -$141K | 0.11% | 90 |
|
|
2025
Q4 | $2.48M | Sell |
99,438
-29,168
| -23% | -$736K | 0.11% | 92 |
|
|
2025
Q3 | $3.28M | Sell |
128,606
-7,538
| -6% | -$186K | 0.14% | 89 |
|
|
2025
Q2 | $3.3M | Sell |
136,144
-464
| -0.3% | -$10.8K | 0.15% | 81 |
|
|
2025
Q1 | $3.14M | Sell |
136,608
-532,631
| -80% | -$13.9M | 0.15% | 82 |
|
|
2024
Q4 | $17.5M | Sell |
669,239
-34,324
| -5% | -$931K | 0.83% | 40 |
|
|
2024
Q3 | $19.7M | Hold |
703,563
| – | – | 1% | 34 |
|
|
2024
Q2 | $19.7M | Buy |
703,563
+14,997
| +2% | +$413K | 0.98% | 35 |
|
|
2024
Q1 | $19.1M | Buy |
688,566
+3,176
| +0.5% | +$88.1K | 1.01% | 37 |
|
|
2023
Q4 | $19.7M | Sell |
685,390
-21,110
| -3% | -$638K | 1.12% | 37 |
|
|
2023
Q3 | $23.4M | Sell |
706,500
-5,154
| -0.7% | -$182K | 1.46% | 30 |
|
|
2023
Q2 | $26.1M | Buy |
711,654
+12,773
| +2% | +$497K | 1.55% | 27 |
|
|
2023
Q1 | $28.5M | Sell |
698,881
-6,740
| -1% | -$291K | 1.76% | 26 |
|
|
2022
Q4 | $36.2M | Buy |
705,621
+6,180
| +0.9% | +$296K | 2.32% | 14 |
|
|
2022
Q3 | $30.6M | Sell |
699,441
-7,063
| -1% | -$343K | 2.17% | 17 |
|
|
2022
Q2 | $37M | Buy |
706,504
+13,719
| +2% | +$699K | 2.42% | 9 |
|
|
2022
Q1 | $35.9M | Buy |
692,785
+7,142
| +1% | +$371K | 2.26% | 16 |
|
|
2021
Q4 | $40.5M | Sell |
685,643
-1,398
| -0.2% | -$69.3K | 2.47% | 11 |
|
|
2021
Q3 | $29.6M | Buy |
687,041
+4,947
| +0.7% | +$219K | 1.98% | 19 |
|
|
2021
Q2 | $26.7M | Buy |
682,094
+40,648
| +6% | +$1.58M | 1.8% | 21 |
|
|
2021
Q1 | $23.2M | Sell |
641,446
-30,659
| -5% | -$1.09M | 1.72% | 21 |
|
|
2020
Q4 | $24.7M | Buy |
672,105
+21,868
| +3% | +$802K | 1.9% | 19 |
|
|
2020
Q3 | $22.6M | Sell |
650,237
-41,967
| -6% | -$1.47M | 2.19% | 20 |
|
|
2020
Q2 | $21.5M | Sell |
692,204
-6,396
| -0.9% | -$217K | 1.98% | 20 |
|
|
2020
Q1 | $21.6M | Buy |
698,600
+25,659
| +4% | +$874K | 2.25% | 12 |
|
|
2019
Q4 | $25M | Sell |
672,941
-6,971
| -1% | -$248K | 2.13% | 15 |
|
|
2019
Q3 | $23.2M | Buy |
679,912
+4,750
| +0.7% | +$173K | 2% | 20 |
|
|
2019
Q2 | $27.8M | Sell |
675,162
-3,036
| -0.4% | -$121K | 2.3% | 7 |
|
|
2019
Q1 | $27.3M | Sell |
678,198
-3,617
| -0.5% | -$145K | 2.32% | 8 |
|
|
2018
Q4 | $28.2M | Sell |
681,815
-5,605
| -0.8% | -$233K | 2.64% | 7 |
|
|
2018
Q3 | $28.7M | Buy |
687,420
+24,699
| +4% | +$951K | 2.43% | 8 |
|
|
2018
Q2 | $22.8M | Buy |
662,721
+15,794
| +2% | +$540K | 2.14% | 13 |
|
|
2018
Q1 | $21.8M | Buy |
646,927
+21,451
| +3% | +$737K | 2.11% | 14 |
|
|
2017
Q4 | $21.5M | Buy |
625,476
+37,844
| +6% | +$1.29M | 2.08% | 14 |
|
|
2017
Q3 | $19.9M | Sell |
587,632
-5,260
| -0.9% | -$169K | 2.22% | 13 |
|
|
2017
Q2 | $18.9M | Buy |
592,892
+5,484
| +0.9% | +$173K | 2.15% | 13 |
|
|
2017
Q1 | $19.1M | Buy |
587,408
+4,510
| +0.8% | +$142K | 2.26% | 12 |
|
|
2016
Q4 | $18M | Buy |
582,898
+10,116
| +2% | +$309K | 2.32% | 13 |
|
|
2016
Q3 | $18.4M | Buy |
572,782
+6,057
| +1% | +$203K | 2.64% | 6 |
|
|
2016
Q2 | $18.9M | Sell |
566,725
-24,488
| -4% | -$782K | 2.88% | 4 |
|
|
2016
Q1 | $16.6M | Buy |
591,213
+50,022
| +9% | +$1.43M | 2.59% | 10 |
|
|
2015
Q4 | $16.6M | Buy |
541,191
+17,081
| +3% | +$537K | 2.74% | 9 |
|
|
2015
Q3 | $15.6M | Buy |
524,110
+8,731
| +2% | +$280K | 2.79% | 7 |
|
|
2015
Q2 | $16.4M | Buy |
515,379
+5,101
| +1% | +$166K | 2.75% | 7 |
|
|
2015
Q1 | $16.8M | Buy |
510,278
+6,174
| +1% | +$196K | 2.82% | 6 |
|
|
2014
Q4 | $14.9M | Buy |
504,104
+13,895
| +3% | +$398K | 2.56% | 8 |
|
|
2014
Q3 | $13.8M | Buy |
490,209
+5,833
| +1% | +$164K | 2.54% | 7 |
|
|
2014
Q2 | $13.6M | Sell |
484,376
-3,427
| -0.7% | -$97.7K | 2.53% | 7 |
|
|
2014
Q1 | $14.9M | Sell |
487,803
-14,703
| -3% | -$438K | 2.86% | 5 |
|
|
2013
Q4 | $14.6M | Buy |
502,506
+48,061
| +11% | +$1.4M | 2.75% | 5 |
|
|
2013
Q3 | $12.4M | Buy |
454,445
+8,452
| +2% | +$230K | 2.98% | 4 |
|
|
2013
Q2 | $11.9M | Buy |
+445,993
| New | +$12.3M | 3.28% | 4 |
|
Other funds holding PFE
Berkshire Asset Management's PFE Position: Q2 2026 in Review
Berkshire Asset Management reduced its Pfizer (PFE) stake by 6.9% in Q2 2026, selling an estimated $170K and leaving 87,660 shares worth $2.11M. The position accounts for 0.08% of the portfolio, ranked #103.
Berkshire Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $40.5M in Q4 2021. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Berkshire Asset Management held 87,660 shares of Pfizer worth $2.11M as of Q2 2026.
- Berkshire Asset Management sold 6,485 Pfizer shares in Q2 2026, an estimated $170K.
- Pfizer made up 0.08% of Berkshire Asset Management's portfolio in Q2 2026, its #103 holding.
- Berkshire Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Berkshire Asset Management's Pfizer position peaked at $40.5M in Q4 2021.
- 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Berkshire Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.